Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia
about
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence.Pseudomonas Endocarditis with an unstable phenotype: the challenges of isolate characterization and Carbapenem stewardship with a partial review of the literature.The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action.Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.
P2860
Q26771848-F04C1E81-7ECA-41B9-A66B-F841B599211FQ37287648-B5C79F15-0EAF-4EFF-A126-55F5FBD772EFQ39702978-8687944B-0914-4212-A1A1-D89FC273F5FBQ40073768-64A02C8A-8071-4023-A651-48B65F517894Q40157277-586E0C8A-4AC0-4583-B21A-62F8EC63B532Q40306198-591AF076-558B-443D-96B3-CD4E8F2F4451Q40657200-CA25CA59-28E6-4DC1-B589-BCBEF60CAF42Q41244127-1B29003D-56DF-484D-AC7C-18D319F12785Q47656109-EC9CAE9B-56F7-40D7-80C2-9378CCBCE76EQ47661746-053DB209-7774-4E33-BF9A-7BE703307C46Q48602238-2842D944-A535-4AAE-B176-6D21341D2190
P2860
Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Combination treatment with mer ...... in a murine model of pneumonia
@ast
Combination treatment with mer ...... in a murine model of pneumonia
@en
type
label
Combination treatment with mer ...... in a murine model of pneumonia
@ast
Combination treatment with mer ...... in a murine model of pneumonia
@en
prefLabel
Combination treatment with mer ...... in a murine model of pneumonia
@ast
Combination treatment with mer ...... in a murine model of pneumonia
@en
P2093
P2860
P356
P1476
Combination treatment with mer ...... in a murine model of pneumonia
@en
P2093
Alan Schumitzky
Arnold Louie
David Brown
Dodge Baluya
George L Drusano
Michael N Neely
Michael VanGuilder
Nichole Robbins
Roger Jelliffe
Stephanie Kurhanewicz
P2860
P304
P356
10.1093/INFDIS/JIU603
P407
P577
2014-10-31T00:00:00Z